It was found that the brain tissue and cerebrospinal fluid of AD patients presented increased IL-1β and TNFα levels [11], inhibiting microglial phagocytosis, which in turn intensifies Aβ accumulation and neuroinflammation [12, 13]. The gene discussed is IL1B; the disease is Alzheimer disease.